Hanoi Pharma JSC engages in the manufacture of pharmacy products. Its products include eye drops, analgesic, vitamin, medicine and toothache. The company was on February 22, 1993 and is headquartered in Ha Noi, Vietnam.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DHN is 30,000 VND — it has decreased by −1.02% in the past 24 hours. Watch HANOI PHARMAR JSC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on UPCOM exchange HANOI PHARMAR JSC stocks are traded under the ticker DHN.
DHN stock has risen by 20.83% compared to the previous week, the month change is a 20.83% rise, over the last year HANOI PHARMAR JSC has showed a 42.86% increase.
DHN reached its all-time high on Dec 28, 2021 with the price of 35,300 VND, and its all-time low was 8,500 VND and was reached on Jun 22, 2018. View more price dynamics on DHN chart. See other stocks reaching their highest and lowest prices.
No, DHN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DHN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANOI PHARMAR JSC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANOI PHARMAR JSC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANOI PHARMAR JSC stock shows the buy signal. See more of HANOI PHARMAR JSC technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.